Adjuvant chemotherapy: Controversies and the role of taxanes

Breast Journal

Volumn 9, Issue SUPPL. 1, 2003, Pages

  Perez, Edith ^a,b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; PACLITAXEL; TAXANE DERIVATIVE;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; HUMAN; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

EID: 0037263528     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.9.s1.6.x     Document Type: Conference Paper

References (6)

1. Henderson IC, Berry D, Demetri G, et al. Improved disease-free survival and overall survival from the addition of sequential paclitaxel but not from the escalation of doxorubicin dose level in the adjuvant chemotherapy of node-positive breast cancer [abstract 390A]. Proc Am Soc Clin Oncol 1998;17:101a.
2. National Institutes of Health Consensus Development, November 2000 (available at http://consensus.nih.gov/cons/114/114_intro.htm).
3. Nabholtz JM, Pienkowski T, Mackey M, et al. Phase III trial comparing TAC (docetaxel, doxorubicin, cyclophosphamide) with FAC (5-fluorouracil, doxorubicin, cyclophosphamide) in the adjuvant treatment of node positive breast cancer (BC) patients: interim analysis of the BCIRG 001 study [abstract 141]. Proc Am Soc Clin Oncol 2002;21:36a.
4. Bear H, on behalf of NSABP Investigators. The effect on primary tumor response of adding sequential Taxotere to Adriamycin and cyclophosphamide: preliminary results from the NSABP protocol B-27 [abstract 5]. Breast Cancer Res Treat 2001;69:210.
5. Kuerer HM, Newman LA, Smith TL, et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary node response to doxorubicin-based neoadjuvant therapy. J Clin Oncol 1999;17:460-69.
6. Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998;16:2672-85.